Q1 2026 semaglutide cohort: -12.4% mean weight at 24 weeks, -16.8% at 52 weeks (subset), 19.2% twelve-week dropout, 35.6% nausea, , USP , HPLC potency) are available on request, (4) the full out-of-pocket monthly cost across the titration schedule, (5) the FDA-approval status of any medication you're prescribed
Tang X, Wu H, Mao X, Li X, Wang Y (2020) The GLP-1 receptor herbal agonist morroniside attenuates neuropathic pain via spinal microglial expression of IL-10 and -endorphin
May 2025: Illumina and Ovation.io developed a clinical multiomic dataset from 25,000 GLP-1 therapy patients to support drug discovery
About 8 states have telemedicine prescribing restrictions that go beyond federal rules, effectively banning or limiting remote controlled-substance prescribing